Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Basic): 2019-2024

Historic EPS (Basic) for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to -$0.33.

  • Biodesix's EPS (Basic) rose 17.14% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 331.58%. This contributed to the annual value of -$0.33 for FY2024, which is 48.44% up from last year.
  • Biodesix's EPS (Basic) amounted to -$0.33 in FY2024, which was up 48.44% from -$0.64 recorded in FY2023.
  • In the past 5 years, Biodesix's EPS (Basic) registered a high of -$0.33 during FY2024, and its lowest value of -$6.48 during FY2020.
  • Over the past 3 years, Biodesix's median EPS (Basic) value was -$0.64 (recorded in 2023), while the average stood at -$0.84.
  • Data for Biodesix's EPS (Basic) shows a peak YoY surged of 94.90% (in 2020) over the last 5 years.
  • Biodesix's EPS (Basic) (Yearly) stood at -$6.48 in 2020, then soared by 75.62% to -$1.58 in 2021, then increased by 1.90% to -$1.55 in 2022, then soared by 58.71% to -$0.64 in 2023, then surged by 48.44% to -$0.33 in 2024.